When.com Web Search

  1. Ads

    related to: pfeiffer syndrome clinical trials gene therapy

Search results

    1.98+0.04 (+2.06%)

    at Fri, May 31, 2024, 4:00PM EDT - U.S. markets closed

    Nasdaq Real Time Price

    • Open 1.94
    • High 2.13
    • Low 1.91
    • Prev. Close 1.94
    • 52 Wk. High 5.15
    • 52 Wk. Low 1.67
    • P/E N/A
    • Mkt. Cap 6.43M
  1. Results From The WOW.Com Content Network
  2. Pfeiffer syndrome - Wikipedia

    en.wikipedia.org/wiki/Pfeiffer_syndrome

    Pfeiffer syndrome is a rare genetic disorder, characterized by the premature fusion of certain bones of the skull (craniosynostosis), which affects the shape of the head and face. The syndrome includes abnormalities of the hands and feet, such as wide and deviated thumbs and big toes.

  3. Jesse Gelsinger - Wikipedia

    en.wikipedia.org/wiki/Jesse_Gelsinger

    Jesse Gelsinger (June 18, 1981 – September 17, 1999) was the first person publicly identified as having died in a clinical trial for gene therapy. Gelsinger suffered from ornithine transcarbamylase deficiency , an X-linked genetic disease of the liver , the symptoms of which include an inability to metabolize ammonia – a byproduct of ...

  4. Gene therapy in Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Gene_therapy_in_Parkinson's...

    There are many new PD treatments in clinical trials and several of those are focusing on gene therapeutic approaches that compensate the loss of dopamine or protect the nervous system dopamine neurons from degeneration.

  5. FDA approves Pfizer's first gene therapy for rare ... - AOL

    www.aol.com/news/fda-approves-pfizer-first-gene...

    The Food and Drug Administration on Friday approved Pfizer ’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.

  6. Genetic disorder - Wikipedia

    en.wikipedia.org/wiki/Genetic_disorder

    The treatment of genetic disorders is an ongoing battle, with over 1,800 gene therapy clinical trials having been completed, are ongoing, or have been approved worldwide. Despite this, most treatment options revolve around treating the symptoms of the disorders in an attempt to improve patient quality of life .

  7. X-linked severe combined immunodeficiency - Wikipedia

    en.wikipedia.org/wiki/X-linked_severe_combined...

    Gene therapy is another treatment option which is available only for clinical trials. X-linked SCID is a monogenic disorder, the IL2RG gene is mutated, so gene therapy will replace this mutated gene with a normal one. This will result in a normal functioning gamma chain protein of the interleukin receptor.